Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Molecular and Cellular Biology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
CELL GROWTH AND DEVELOPMENT

Fission Yeast Rad17 Associates with Chromatin in Response to Aberrant Genomic Structures

Mihoko Kai, Hiroyuki Tanaka, Teresa S.-F. Wang
Mihoko Kai
Department of Pathology, Stanford University School of Medicine, Stanford, California 94305-5324, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroyuki Tanaka
Department of Biochemistry and Molecular Biology, The University of Tokyo Graduate School of Medicine, Bunkyo-ku, Tokyo 113-0033, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teresa S.-F. Wang
Department of Pathology, Stanford University School of Medicine, Stanford, California 94305-5324, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/MCB.21.10.3289-3301.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Fig. 1.
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Chromatin binding of Rad17 is enhanced following DNA damage. (A) Schematic outline of the chromatin fractionation assay. Details of the assay are described in Materials and Methods. Histone H4 and α-tubulin were used as controls for chromatin-bound and non-chromatin-bound proteins in either hydroxyurea- or MMS-treated or -untreated cells with anti-acetyl-histone H4 (Lys 16) polyclonal antibody (Upstate Biotechnology) or antitubulin monoclonal antibody, respectively. HU, hydroxyurea. (B) Chromatin association of Rad17 and Rfc2 following MMS treatment. Cells were grown in 0.05% MMS. At the indicated times, cells were fractionated as outlined for panel A and as described in Materials and Methods. Spheroplasts were prepared from cells containing rad17 +:myc(left panel) or rfc2 +:HA(right panel). Twenty micrograms of total protein, an equivalent volume of the supernatant (Sup), and five volume equivalents of chromatin-bound proteins (Chr) were fractionated on an 8% SDS gel and analyzed by Western blotting with anti-myc monoclonal antibody (9E10). (C) Chromatin association of Rad17 after ionizing radiation. Cells containing rad17:myc were irradiated with 250 Gy and recovered by incubation at 25°C for 20 min and fractionated as described for panel A. (D) Total cell extracts were prepared under denaturing conditions from wild-type (untaggedrad17 +) and myc-taggedrad17 + cells and were probed with anti-myc antibody. The arrows mark the two forms of Rad17:myc.

    • Open in new tab
    • Download powerpoint
    • Open in new tab
    • Download powerpoint
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    The chromatin binding of Rad17 in response to S-phase perturbation. (A) The mid-log-phaserad17 +:myc strain was incubated in medium containing 12 mM hydroxyurea. At the indicated times, cell samples were removed for FACS analysis and chromatin fractionation assay by probing with anti-myc monoclonal antibody. (B) Rfc1 and Rfc2 were chromatin bound in cells grown in hydroxyurea. Mid-log-phase cells expressed Rfc1:HA in arad17 + background, or Rfc2:HA in arad17 + or rad17Δ background was incubated in medium with 12 mM hydroxyurea for 3 h. Chromatin fractionation assay was performed and analyzed by Western blotting and was probed with anti-HA monoclonal antibody. (C) Mid-log-phase cells ofrad17 +:myc in acdc22-M45 background grown at 25°C were shifted to 36°C for 3 h. Cell samples grown at 25 and 36°C were removed for chromatin fractionation assay. (D) Mid-log-phase cells that expressed Rad17:myc from genomic loci in cdc20 andpolαts13 backgrounds grown at 25°C were shifted to 36°C for 2 h. Chromatin fractionation was performed, analyzed by Western blotting, and probed with anti-myc monoclonal antibody. (E) Mid-log-phase cells that expressed Rad17:myc from genomic loci incds1Δ and rad3Δ backgrounds were incubated in media containing 12 mM hydroxyurea. Chromatin fractionation assay was performed and analyzed by Western blotting and was probed with anti-myc monoclonal antibody.

  • Fig. 3.
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    The checkpoint-defective Rad17(k118E) mutant protein localizes in the nucleus but has reduced ability to bind chromatin. (A) Logarithmically growing rad17Δ cells harboring pREP41-myc-rad17 + or pREP41-myc-rad17.K118E and wild-type untaggedrad17 + cells were harvested and processed for immunofluorescence analysis as described in Materials and Methods. (B) Chromatin fractionation assay was performed with logarithmically growing rad17Δ cells harboring pREP41-myc-rad17 + or pREP41-myc-rad17.K118E as described in Materials and Methods. (C) Cds1 kinase activities of therad17 + wild type and mutantrad17.K118E in the presence of 12 mM hydroxyurea. The indicated strains were grown at 25°C in either the absence or presence of 12 mM hydroxyurea for 3 h. Cds1 was immunoprecipitated from 1 mg of soluble protein and assayed for kinase activity as described in Materials and Methods (upper panel, 32P). The relative amounts of Cds1 used in the kinase assay were estimated by Western blotting (lower panel, anti-myc).

  • Fig. 4.
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Purified Rad17 protein, but not the checkpoint-defective Rad17(K118E) mutant protein, binds ATP in vitro. (A) Silver-stained polyacrylamide gel of 0.2 μg of purified wild-type Rad17 and mutant Rad17(K118E) proteins. (B) Wild-type Rad17, but not mutant Rad17(K118E), binds ATP. [γ-32P]ATP was incubated with purified Rad17 (left panel) or purified mutant Rad17(K118E) protein (right panel) in the presence or absence of 96-mer oligonucleotide or M13 DNA and was processed as described in Materials and Methods. The bottom panel shows the Western blot analysis of the purified Rad17 and Rad17(K118E) proteins used for the ATP binding assay.

  • Fig. 5.
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Rad17 from a checkpoint-defective mutant,rad17.K118E, has reduced ability to associate with Rfc2. (A) Wild-type Rad17 can complex with Rfc2 but not with Rfc1. Crude cell lysates were prepared from 5 × 108 rad17Δ cells expressing either the HA-taggedrfc1 + or HA-tagged rfc2 +at their endogenous chromosomal loci and myc-Rad17 from pREP41-myc-rad17 +. Cell lysates (300 μl) containing 1 mg of protein were used for immunoprecipitation (IP) by anti-HA antibody. The immunoprecipitates were Western blotted with either anti-HA (right panel) or anti-myc monoclonal antibody (left panel). (B) Mutant Rad17(K118E) from a checkpoint-defective strain has significantly reduced ability to associate with Rfc2. Lysates from 5 × 108 rad17Δ cells containing HA-tagged rfc2 + at its endogenous chromosomal locus and pREP41-myc-rad(K118E) were prepared and immunoprecipitated with anti-HA monoclonal antibody, and the immunoprecipitates were analyzed as for panel A. The cell lysate panels show that all strains have adequate expression of the epitope-tagged proteins. (C) Association of wild-type Rad17 and mutant Rad17(K118E) proteins with Rfc2 following MMS treatment. Strains described for panels A and B were grown in 0.05% MMS for 3 h. Cells (5 × 108) were removed for immunoprecipitation with anti-HA monoclonal antibody and were probed with anti-myc monoclonal antibody. (D) Association of wild-type Rad17 and mutant Rad17(K118E) proteins with Rfc2:HA following hydroxyurea (HU) treatment. Cells (5 × 108) from strains described for panels A and B were grown in media containing 12 mM hydroxyurea for 3 h. Cell lysates were prepared and immunoprecipitated with anti-HA monoclonal antibody and Western blotted with anti-myc monoclonal antibody.

  • Fig. 6.
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Cells with deletion of rfc1 are checkpoint proficient. (A) Restriction map and open reading frame (ORF) ofrfc1 +. A 1.8-kb ura4 +gene cassette was used to replace 1.7 kb of theEcoRI-PstI coding region as described in Materials and Methods. (B) rfc1 + is an essential gene. Spores derived from the heterozygous diploidrfc1 +/rfc1Δ were analyzed by tetrad dissection after incubation on yeast extract agar plates at 30°C for 4 days. The 2:2 segregation of the germinating spores indicates thatrfc1 + is essential for cell viability. (C) Germinating rfc1Δ spores have elongated cell morphology. Shown are cells derived from a single germinating spore. (D) Cells withrfc1Δ have intact checkpoint processes. DAPI staining of germinating rfc1Δ spores having elongated cell morphology and normal nuclear morphology is shown. (E) FACS profiles. Heterozygous diploid rfc1 +/rfc1Δ and controlura4 +/ura4D-18 diploid cells were germinated at 30°C in minimal media lacking uracil. Germinating spores were collected every 2 h, fixed with 70% ethanol, and analyzed by FACS as described in Materials and Methods. The positions of 1C and 2C DNA peaks are indicated.

  • Fig. 7.
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    A proposed model illustrating how Rad17 binds to chromatin in response to aberrant genomic structures induced by damage, replication mutant arrest, and hydroxyurea block in the presence or absence of an activated Cds1 kinase. P, phosphorylation.

PreviousNext
Back to top
Download PDF
Citation Tools
Fission Yeast Rad17 Associates with Chromatin in Response to Aberrant Genomic Structures
Mihoko Kai, Hiroyuki Tanaka, Teresa S.-F. Wang
Molecular and Cellular Biology May 2001, 21 (10) 3289-3301; DOI: 10.1128/MCB.21.10.3289-3301.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Molecular and Cellular Biology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Fission Yeast Rad17 Associates with Chromatin in Response to Aberrant Genomic Structures
(Your Name) has forwarded a page to you from Molecular and Cellular Biology
(Your Name) thought you would be interested in this article in Molecular and Cellular Biology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Fission Yeast Rad17 Associates with Chromatin in Response to Aberrant Genomic Structures
Mihoko Kai, Hiroyuki Tanaka, Teresa S.-F. Wang
Molecular and Cellular Biology May 2001, 21 (10) 3289-3301; DOI: 10.1128/MCB.21.10.3289-3301.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Cell Cycle Proteins
Genome, Fungal
Schizosaccharomyces

Related Articles

Cited By...

About

  • About MCB
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #MCBJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0270-7306; Online ISSN: 1098-5549